Bhekisisa

Struggling to figure out when your turn for a COVID vaccine will arrive? Bhekisisa and Media Hack have teamed up to create infographics that make it easier to decipher. This is a living document: when the timeline or guidelines change, we will create an updated graphic and upload it here.

Vaccines will only be registered for use in South Africa if their common side-effects are mild. To qualify as a “very rare” side-effect, the symptom needs to affect fewer than one in 10 000 people. Here’s why.

The high demand for COVID vaccines means there is limited global supplies. Local manufacturing is one potential solution to this problem. So why isn’t South Africa making its own jabs? Find out.

Access to oxygen could mean the difference between living or dying for a COVID patient. But developing countries lack the infrastructure to produce liquid oxygen and transport it to hospitals. Now a team of scientists at Cambridge University has come up with a solution.

Simply identifying hotspots doesn’t explain why some places report more gender-based violence than others. This limits our understanding of the problem, and our ability to find a solution.

This short video answers key questions you might have if you’re in line for the Johnson & Johnson COVID-19 vaccine.

South Africa is rushing to roll out its first national gender-based violence action plan. But as bureaucracy and the coronavirus pandemic stall progress, violence against women continues unabated. And the hot spots that will receive extra resources, it seems, have been wrongly identified.

A lack of access to basic necessities is not just an inconvenience, but a health and safety risk for people in these Western Cape communities. Find out why residents want government to do more.

The Sisonke trial, that was paused earlier this month because of the US government's regulator the Food and Drug Administration's , investigation into rare blood clotting disorders associated with the Johnson & Johnson jab, will resume on Wednesday, April 28th.

Setting up a continent-wide medicines regulator in Africa could be key to getting the continent’s people the treatments and COVID vaccines they need. Here’s why more countries need to put their weight behind it.